Ulocuplumab

(Synonyms: BMS 936564; MDX 1338; Anti-Human CXCR4 Recombinant Antibody)
1 Cited Publications
Kundenbewertung

Based on 1 publication(s) in Google Scholar

Ulocuplumab (Anti-Human CXCR4 Recombinant Antibody/BMS-936564/MDX1338) is a fully human IgG4 anti-CXCR4 antibody. Ulocuplumab induces apoptosis and inhibits CXCL12 mediated CXCR4 activation-migration of chronic lymphocytic leukemia (CLL). Ulocuplumab exhibits antitumor activity in established tumors including acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL), and multiple myeloma xenograft models.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 99.90%
  • CAS. Nr.: 1375830-34-4
  • Molecular Weight:144.84 kDa
  • Speicherung:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biologische Aktivität
  • Chemical Information
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Ulocuplumab

More

Alle CXCR Isoform-spezifische Produkte anzeigen

More
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00